Karo Bio AB Announces Extension of Existing Collaboration With Pfizer Inc. to Discover and Develop Drugs for Autoimmune Disease

Published: Jun 26, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

STOCKHOLM, 26 June 2013 –Karo Bio AB (publ) announced today the extension of its existing research collaboration with Pfizer Inc. on RORgamma modulators to the end of 2014. Pfizer will continue to provide full funding for the research costs.

Help employers find you! Check out all the jobs and post your resume.

Back to news